Skip to main content

Table 5 Total direct and indirect out-of-pocket costs accrued by patients with advanced NSCLC and their caregivers by disease stage

From: Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

 

Patients

Caregivers

Mean annual cost outcome

Stage IIIB (n = 119)

Stage IV

(n = 911)

Stage IIIB (n = 30)

Stage IV

(n = 397)

Total direct and indirect out-of-pocket costs (unadjusted)

n = 51

€3528

n = 471

€5925

n = 19

€2232

n = 185

€4319

Financial support received from government

n = 110

€737

n = 879

€2282

n = 29

€663

n = 357

€726

Total direct and indirect out-of-pocket costs (adjusteda)

n = 50

€2548

n = 468

€2654

n = 18

€2241

n = 176

€3603

  1. NSCLC non-small cell lung cancer
  2. aAdjusted for financial support provided by the respective governments